|
DNAJB4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6952000348478E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.44919997802884E-09 |
| Normal-vs-Stage2 |
1.78780001913736E-09 |
| Normal-vs-Stage3 |
1.82140003079923E-09 |
| Normal-vs-Stage4 |
5.77250025557419E-10 |
| Stage1-vs-Stage2 |
7.991800E-02 |
| Stage1-vs-Stage3 |
9.604400E-02 |
| Stage1-vs-Stage4 |
2.458200E-02 |
| Stage2-vs-Stage3 |
9.073000E-01 |
| Stage2-vs-Stage4 |
3.825400E-01 |
| Stage3-vs-Stage4 |
3.205400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85169995897883E-09 |
| Normal-vs-AfricanAmerican |
1.09450000174149E-08 |
| Normal-vs-Asian |
3.15079999868573E-08 |
| Caucasian-vs-AfricanAmerican |
8.360400E-01 |
| Caucasian-vs-Asian |
6.462800E-01 |
| AfricanAmerican-vs-Asian |
8.261200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07590003572966E-09 |
| Normal-vs-Female |
6.45830000589598E-09 |
| Male-vs-Female |
1.852410E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.38860001064734E-09 |
| Normal-vs-Age(41-60Yrs) |
5.11209996556516E-09 |
| Normal-vs-Age(61-80Yrs) |
1.46750001039919E-09 |
| Normal-vs-Age(81-100Yrs) |
4.30950000018804E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.530800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.227010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.450000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.536400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.666400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.020800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.47570003070786E-09 |
| Classical-VS-Follicular |
9.476600E-01 |
| Classical-VS-Other |
5.998400E-01 |
| Classical-VS-Normal |
8.74460004407496E-09 |
| Tall-VS-Follicular |
5.55249999999452E-05 |
| Tall-VS-Other |
1.791780E-01 |
| Tall-VS-Normal |
9.19739839844169E-11 |
| Follicular-VS-Other |
6.059600E-01 |
| Follicular-VS-Normal |
1.13020000025443E-08 |
| Other-VS-Normal |
2.06029999727519E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.67149996463689E-09 |
| Normal-vs-N1 |
9.18230047552981E-10 |
| N0-vs-N1 |
1.645360E-01 |
|
|
